🔥 Wednesday 25 February 2026 Wed, 25 Feb 2026
49 Big Stories
Aurora Energy Metals Secures A$24.2M in Eagle Shares with Uranium Project Sale
Aurora Energy Metals has completed the sale of its Aurora Uranium Project to Eagle Nuclear Energy, receiving A$24.2 million in equity and retaining future milestone-linked payments and royalties.
25 Feb
Maxwell Dee
Artrya Advances US Commercialisation with FDA Nod and $80M Capital Boost
Artrya Limited reported a 44% increase in its half-year loss to $10.7 million as it transitioned from development to commercial operations in the US, securing FDA clearance and signing three foundation customers. An $80 million capital raise underpins its ambitious US expansion and ongoing product development.
25 Feb
Ada Torres
Sprintex Secures €15.6m European Order, Narrows Loss Amid Growth Push
Sprintex Limited reported a 162% surge in revenue to A$2.7 million for the half-year ending December 2025, driven by a landmark €15.6 million European contract. Despite this, the company posted a net loss of A$1.7 million, an improvement from the prior year, while raising $3.6 million to support global expansion.
25 Feb
Victor Sage
CTI Logistics Surges with 64% Profit Jump and Strategic WA Expansion
CTI Logistics has reported a robust half-year performance with revenue climbing 7.6% and profit before tax soaring 64.2%, underpinned by operational efficiencies and strategic investments in Western Australia.
25 Feb
Victor Sage
Mayfield Group Expands Underground Mining Reach with $30M SMEC Acquisition
Mayfield Group Holdings has announced the acquisition of SMEC Power & Technology for up to $30 million, marking its entry into underground mining electrical infrastructure and international markets.
25 Feb
Victor Sage
FortifAI Halves Losses, Acquires AI Tech, and Raises $5M to Fuel Growth
FortifAI Limited reported a 51% revenue decline but a 70% reduction in net loss for H1 FY26, alongside completing a major AI technology acquisition and securing $5 million in fresh capital.
25 Feb
Sophie Babbage
NEXTDC Accelerates Growth with Record Contracted Capacity and Expanded Capital Plans
NEXTDC has reported a robust first half of FY26, with strong revenue and earnings growth underpinned by a surging forward order book and expanded capital expenditure plans.
25 Feb
Sophie Babbage
Kingsgate Surges to $88M Profit, Declares 10c Dividend Amid Production Boost
Kingsgate Consolidated Limited has reported a spectacular half-year performance with a 3,491% jump in net profit and a doubling of revenue, driven by higher gold and silver production. The company also declared its first interim dividend in years, signalling confidence in its growth trajectory.
25 Feb
Maxwell Dee
Cyclopharm’s US Surge Drives Record $32.3M Revenue Amid Strategic Growth Push
Cyclopharm Limited reported a 17% revenue increase to a record $32.3 million in 2025, powered by a 226% surge in US Technegas sales. The company is accelerating its US rollout with plans for up to 300 installations in 2026, while advancing clinical trials beyond pulmonary embolism.
25 Feb
Ada Torres
EcoGraf’s Epanko BFS Unveils $516M NPV and 73,000tpa Production Boost
EcoGraf Limited has completed a comprehensive update to its Bankable Feasibility Study for the Epanko Graphite Project, confirming robust financials and a production increase to 73,000 tonnes per annum. The study underpins advanced project financing and highlights significant expansion potential amid rising global graphite demand.
25 Feb
Maxwell Dee
Island Pharmaceuticals Expands Pipeline with Galidesivir Amid Rising Losses
Island Pharmaceuticals reports a 213.8% increase in half-year loss to $4.81 million, driven by strategic acquisition and clinical development investments. The company advances its antiviral portfolio with Galidesivir and ISLA-101, supported by strong US regulatory engagement and a $9 million capital raise.
25 Feb
Ada Torres
Immuron Advances with FDA Nod and Record Sales Despite Ongoing Losses
Immuron Limited reported a narrower half-year loss alongside record sales growth and FDA approval for its IMM-529 drug candidate, signalling promising clinical and commercial momentum.
25 Feb
Ada Torres
RocketDNA Scales Up Autonomous Drone Operations with 6% Revenue Growth in 2025
RocketDNA Ltd reported a 6% increase in revenue to AUD 76.83 million for the year ended 31 December 2025, expanding its autonomous drone footprint across Australia and Africa while securing major mining contracts.
25 Feb
Sophie Babbage
Acorn Capital Investment Fund Surges with 306% Revenue Growth and 3.5c Dividend
Acorn Capital Investment Fund Limited has reported a remarkable half-year performance for the period ending 31 December 2025, with revenue and profit soaring over 300%. The fund also declared a fully franked interim dividend of 3.5 cents per share, signalling confidence in its investment strategy.
25 Feb
Claire Turing
Stealth Group Surges with Record 1H26 Results and $500m FY28 Sales Target
Stealth Group Holdings has delivered record half-year results for 1H26, boosted by its strategic acquisition of Hardware & Building Traders and a strengthened balance sheet. The company is now targeting over $500 million in sales by FY28, signalling ambitious growth in Australia's fragmented hardware and industrial distribution market.
25 Feb
Maxwell Dee
MA Credit Income Trust Surpasses Targets with $19.7M Profit and $190.5M Capital Raise
MA Credit Income Trust reported a strong half-year profit of $19.7 million, exceeding its return target, while successfully completing a $190.5 million capital raise and initiating a strategic buy-back to manage liquidity.
25 Feb
Claire Turing
Imugene Cuts Losses, Boosts Azer-cel Trial with FDA Nod and $25M Raise
Imugene Limited reports a narrower half-year loss as it advances its promising azer-cel CAR T therapy with strong clinical results and FDA backing, supported by a $25 million capital raise.
25 Feb
Ada Torres
Regal Investment Fund Surges 201% Profit, Declares 12 CPU Distribution
Regal Investment Fund reported a remarkable half-year performance with a 201% increase in operating profit and a 12 cents per unit distribution declared for December 2025. The Fund's strategic buy-back program and strong net asset growth underscore its robust position.
25 Feb
Victor Sage
Fenix Resources Doubles Revenue and Quadruples Profit in H1 2025
Fenix Resources Ltd has reported a remarkable half-year financial performance with revenue surging 125% and net profit soaring 419% compared to the previous year.
25 Feb
Maxwell Dee
ARN Media’s Strategic Reset Amid Revenue Decline and Leadership Change
ARN Media Limited reported a 10% revenue decline in FY25 alongside a strategic reset focusing on digital transformation and cost savings. Leadership changes and improved cash flow underpin the company’s pivot to a digitally driven entertainment model.
25 Feb
Elise Vega
Pharmx Advances Platform Amid Losses, Seals Strategic Alliance with Sigma Healthcare
Pharmx Technologies reported a 3.1% revenue increase to $3.89 million for H1 FY26 but posted a net loss of $512,000 driven by strategic investments. The company also announced a significant multi-year alliance with Sigma Healthcare.
25 Feb
Sophie Babbage
Compumedics Surges with 32% Revenue Growth and Returns to Profit in H1 FY26
Compumedics Limited has reported a robust half-year performance, with revenue climbing 32% to $31 million and a return to profitability, driven by strong MEG system sales and SaaS growth.
25 Feb
Ada Torres
Tabcorp’s H1 FY26: Revenue Edges Up, Adjusted Profit Surges, Dividend Boosted
Tabcorp Holdings reported a modest 1% revenue increase for the half year ending December 2025, while adjusted net profit after tax jumped 61.5%, prompting a 50% rise in the interim dividend.
25 Feb
Victor Sage
Freelancer Limited Posts Record Profit Amid AI-Driven Growth and Platform Expansion
Freelancer Limited has reported a landmark FY25 with record net profit and revenue growth, powered by strong AI integration and strategic expansion across its core marketplaces.
25 Feb
Sophie Babbage